TGen & Pancreatic Cancer Research
Pancreatic Cancer is a vicious killer, the fourth leading cause of cancer death in the US, claiming a higher percentage of lives than any other form of cancer. Dr. Daniel Von Hoff leads the Clinical Translational Research Division at TGen which focuses on genetic and biochemical approaches to identify diagnostics and molecular targets for the development of new therapies for pancreatic cancer. Dr. Von Hoff and his team were instrumental in the development of an anti-cancer agent (gemcitabine …
Tagged with: cancer, gemcitabine, genetic, genomic, Medicine, nonprofit, pancreatic, pcrt, research, TGen, translational, vonhoffShare this:
Read also:
- Cancer Research UK's new TV advert
- Cancer research? Pppft. This is way better!
- www.giveafewbob.org - Prostate Cancer Research Foundation
- Relay For Life - Redditch 2007 Cancer Research UK by GSINC
- Israeli scientists make gains in cancer research - 20 Nov 09
- Ovarian Cancer Research Fund